Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: stop the merry-go-round, it's time to get off!
Angus
Peter
P
Locarnini
Stephen
S
D020816:Amino Acid Motifs; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000494:pharmacology; D004334:Drug Administration Schedule; D024882:Drug Resistance, Viral; D006509:Hepatitis B / Q000188:drug therapy / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects*; D019259:Lamivudine / Q000008:administration & dosage* / Q000494:pharmacology; D009154:Mutation; D012194:RNA-Directed DNA Polymerase / Q000235:genetics*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology
D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D012194:RNA-Directed DNA Polymerase